Dosage Forms

A pair of medicines manufacturing initiatives are looking to improve continuous direct compression and clinical trial supply.

How can we get macromolecules across the intestinal epithelial barrier?

With the right partner to help you harness the many benefits, nasal delivery is not to be sniffed at.

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Why drug developers should take a fresh look at long-acting dosage forms.

Nominations are now open for The Medicine Maker 2021 Power List.

Formulation fit for the future of complex molecules.

How are counterfeiters exploiting the COVID-19 pandemic to make a profit?

It is essential that drug development incorporates the patient view.

We need to optimize and then accelerate HPAPI drug product development. Alyn McNaughton from Lonza tells us more.